ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/akt activity with retained but inactivated PTEN-A report from the Children's Oncology Group

Cell Lymphoma ◽

Large Cell ◽

Oncology Group ◽

Phosphatidylinositol 3 Kinase ◽

Large Cell Lymphoma ◽

Phosphatidylinositol 3

Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma

OncoTargets and Therapy ◽

10.2147/ott.s59314 ◽

2014 ◽

pp. 789 ◽

Cited By ~ 2

Author(s):

Ulrich Keller ◽

Nicolas Graf ◽

Zhoulei Li ◽

Ken Herrmann ◽

Daniel Weh ◽

...

Keyword(s):

Cell Lymphoma ◽

Large Cell ◽

Positron Emission Tomographic ◽

Phosphatidylinositol 3 Kinase ◽

Mtor Inhibition ◽

Positron Emission ◽

Large Cell Lymphoma ◽

Phosphatidylinositol 3

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

The Lancet Oncology ◽

10.1016/s1470-2045(13)70095-0 ◽

2013 ◽

Vol 14 (6) ◽

pp. 472-480 ◽

Cited By ~ 399

Author(s):

Yael P Mossé ◽

Megan S Lim ◽

Stephan D Voss ◽

Keith Wilner ◽

Katherine Ruffner ◽

...

Keyword(s):

Cell Lymphoma ◽

Phase 1 ◽

Large Cell ◽

Solid Tumours ◽

Oncology Group ◽

Paediatric Patients ◽

Advanced-stage anaplastic large-cell lymphoma in children and adolescents: Results of ANHL0131, a randomized phase III trial with standard APO (doxorubicin, prednisone, vincristine) versus consolidation with a regimen including vinblastine: A report from the Children's Oncology Group.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.9511 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 9511-9511 ◽

Cited By ~ 4

Author(s):

J. M. Kraveka ◽

S. S. Weitzman ◽

L. Smith ◽

J. C. Lynch ◽

M. Chang ◽

...

Keyword(s):

Children And Adolescents ◽

Cell Lymphoma ◽

Large Cell ◽

Phase Iii ◽

Advanced Stage ◽

Oncology Group ◽

Phase Iii Trial ◽

Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.03.023 ◽

2016 ◽

Vol 95 (5) ◽

pp. 1454-1459 ◽

Cited By ~ 12

Author(s):

Lynn Million ◽

Esther J. Yi ◽

Frank Wu ◽

Rie Von Eyben ◽

Belinda A. Campbell ◽

...

Keyword(s):

Radiation Therapy ◽

Radiation Oncology ◽

Cell Lymphoma ◽

Large Cell ◽

Oncology Group ◽

Institutional Experience ◽

Large Cell Lymphoma ◽

Radiation Oncology Group

Advanced stage anaplastic large cell lymphoma in children and adolescents: Results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the children's oncology group

Pediatric Blood & Cancer ◽

10.1002/pbc.25187 ◽

2014 ◽

Vol 61 (12) ◽

pp. 2236-2242 ◽

Cited By ~ 41

Author(s):

Sarah Alexander ◽

Jacqueline M. Kraveka ◽

Sheila Weitzman ◽

Eric Lowe ◽

Lynette Smith ◽

...

Keyword(s):

Children And Adolescents ◽

Cell Lymphoma ◽

Large Cell ◽

Phase Iii ◽

Advanced Stage ◽

Oncology Group ◽

Phase Iii Trial ◽

Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-020-04171-4 ◽

2020 ◽

Vol 86 (6) ◽

pp. 829-840

Author(s):

Emily Greengard ◽

Yael P. Mosse ◽

Xiaowei Liu ◽

Charles G. Minard ◽

Joel M. Reid ◽

...

Keyword(s):

Solid Tumors ◽

Pediatric Patients ◽

Cell Lymphoma ◽

Phase 1 ◽

Large Cell ◽

Cytotoxic Chemotherapy ◽

Oncology Group ◽

Safety and tolerability of crizotinib in combination with chemotherapy for relapsed or refractory solid tumors or anaplastic large cell lymphoma: a Children’s Oncology Group phase I consortium study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.10058 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 10058-10058 ◽

Cited By ~ 1

Author(s):

Emily Gustava Greengard ◽

Yael P. Mosse ◽

Xiaowei Liu ◽

Charlotte H. Ahern ◽

Charles Minard ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Cell Lymphoma ◽

Large Cell ◽

Oncology Group ◽

Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group

Leukemia & Lymphoma ◽

10.1080/10428194.2018.1562182 ◽

2019 ◽

Vol 60 (8) ◽

pp. 1942-1949

Author(s):

Shih-Hsiang Chen ◽

Jiann-Shiuh Chen ◽

Shiann-Tarng Jou ◽

Kang-Hsi Wu ◽

Iou-Jih Hung ◽

...

Keyword(s):

Pediatric Oncology ◽

Cell Lymphoma ◽

Large Cell ◽

Oncology Group ◽

Pediatric Oncology Group ◽

Faculty Opinions recommendation of Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718001601.793477817 ◽

2013 ◽

Author(s):

Neyssa Marina

Keyword(s):

Cell Lymphoma ◽

Phase 1 ◽

Large Cell ◽

Solid Tumours ◽

Oncology Group ◽

Paediatric Patients ◽

Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

10.1055/s-0040-1701850 ◽

2020 ◽

Author(s):

Y Koga ◽

M Sekimizu ◽

A Iguchi ◽

A Kada ◽

A Saito ◽

...

Keyword(s):

Phase I ◽

Phase I Study ◽

Hodgkin’S Lymphoma ◽

Cell Lymphoma ◽

Large Cell ◽

Brentuximab Vedotin ◽

Hodgkin's Lymphoma ◽

Japanese Children ◽